In the last 10 years, the science of frontotemporal dementias has exploded, thanks to big openings in the molecular pathologies behind these disorders. Rapidly growing interest among academia and industry was on display at the 10th International Conference on Frontotemporal Dementias, held August 31 to September 2 in Munich. While the presentations spanned the range of basic to clinical science, there was a dominant theme: a collective push toward trials. Read the entire article here.